Trial Profile
Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sevelamer (Primary) ; Calcium acetate; Calcium carbonate
- Indications Hyperphosphataemia
- Focus Therapeutic Use
- Sponsors Chugai Pharma Taiwan
- 07 Aug 2014 New trial record